Literature DB >> 23300174

Low-dose vemurafenib induces complete remission in a case of hairy-cell leukemia with a V600E mutation.

Frederic Peyrade1, Daniel Re, Clemence Ginet, Lauris Gastaud, Maryline Allegra, Robert Ballotti, Antoine Thyss, Thorsten Zenz, Patrick Auberger, Guillaume Robert.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23300174      PMCID: PMC3561446          DOI: 10.3324/haematol.2012.082404

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  5 in total

1.  BRAF inhibition in refractory hairy-cell leukemia.

Authors:  Sascha Dietrich; Hanno Glimm; Mindaugas Andrulis; Christof von Kalle; Anthony D Ho; Thorsten Zenz
Journal:  N Engl J Med       Date:  2012-05-24       Impact factor: 91.245

2.  BRAF mutations in hairy-cell leukemia.

Authors:  Enrico Tiacci; Vladimir Trifonov; Gianluca Schiavoni; Antony Holmes; Wolfgang Kern; Maria Paola Martelli; Alessandra Pucciarini; Barbara Bigerna; Roberta Pacini; Victoria A Wells; Paolo Sportoletti; Valentina Pettirossi; Roberta Mannucci; Oliver Elliott; Arcangelo Liso; Achille Ambrosetti; Alessandro Pulsoni; Francesco Forconi; Livio Trentin; Gianpietro Semenzato; Giorgio Inghirami; Monia Capponi; Francesco Di Raimondo; Caterina Patti; Luca Arcaini; Pellegrino Musto; Stefano Pileri; Claudia Haferlach; Susanne Schnittger; Giovanni Pizzolo; Robin Foà; Laurent Farinelli; Torsten Haferlach; Laura Pasqualucci; Raul Rabadan; Brunangelo Falini
Journal:  N Engl J Med       Date:  2011-06-11       Impact factor: 91.245

3.  Rapid detection and quantitation of BRAF mutations in hairy cell leukemia using a sensitive pyrosequencing assay.

Authors:  Shalini Verma; Wesley O Greaves; Farhad Ravandi; Neelima Reddy; Carlos E Bueso-Ramos; Susan O'Brien; Deborah A Thomas; Hagop Kantarjian; L Jeffrey Medeiros; Rajyalakshmi Luthra; Keyur P Patel
Journal:  Am J Clin Pathol       Date:  2012-07       Impact factor: 2.493

Review 4.  How I treat hairy cell leukemia.

Authors:  Michael R Grever
Journal:  Blood       Date:  2009-10-20       Impact factor: 22.113

5.  Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1).

Authors:  Brunangelo Falini; Enrico Tiacci; Arcangelo Liso; Katia Basso; Elena Sabattini; Roberta Pacini; Robin Foa; Alessandro Pulsoni; Riccardo Dalla Favera; Stefano Pileri
Journal:  Lancet       Date:  2004-06-05       Impact factor: 79.321

  5 in total
  20 in total

1.  Role of BRAFV600E in the first preclinical model of multifocal infiltrating myopericytoma development and microenvironment.

Authors:  Peter M Sadow; Carmen Priolo; Simona Nanni; Florian A Karreth; Mark Duquette; Roberta Martinelli; Amjad Husain; John Clohessy; Heinz Kutzner; Thomas Mentzel; Christopher V Carman; Antonella Farsetti; Elizabeth Petri Henske; Emanuele Palescandolo; Laura E Macconaill; Seum Chung; Guido Fadda; Celestino Pio Lombardi; Antonina M De Angelis; Oreste Durante; John A Parker; Alfredo Pontecorvi; Harold F Dvorak; Christopher Fletcher; Pier Paolo Pandolfi; Jack Lawler; Carmelo Nucera
Journal:  J Natl Cancer Inst       Date:  2014-07-25       Impact factor: 13.506

Review 2.  Hairy cell leukemia: update and current therapeutic approach.

Authors:  Latif Salam; Omar Abdel-Wahab
Journal:  Curr Opin Hematol       Date:  2015-07       Impact factor: 3.284

Review 3.  [Hairy cell leukemia].

Authors:  S Dietrich; M Andrulis; T Zenz
Journal:  Internist (Berl)       Date:  2015-04       Impact factor: 0.743

4.  Treatment of refractory hairy cell leukemia with a BRAF-inhibitor: lessons to be learnt.

Authors:  Eszter Sári; Zsolt György Nagy; Kornélia Baghy; Hajnalka Rajnai; Csaba Bödör; Judit Csomor; Gábor Barna; Gábor Rudas; Ilona Kovalszky; Judit Demeter
Journal:  Pathol Oncol Res       Date:  2014-05-03       Impact factor: 3.201

5.  BRAF in the cross-hairs.

Authors:  Mark B Geyer; Omar Abdel-Wahab; Martin S Tallman
Journal:  Expert Rev Hematol       Date:  2019-02-26       Impact factor: 2.929

Review 6.  Update on the biology and treatment options for hairy cell leukemia.

Authors:  Preetesh Jain; Naveen Pemmaraju; Farhad Ravandi
Journal:  Curr Treat Options Oncol       Date:  2014-06

7.  BRAF-mutated clear cell sarcoma is sensitive to vemurafenib treatment.

Authors:  Svetlana A Protsenko; Anna I Semionova; Yuri I Komarov; Svetlana N Aleksakhina; Alexandr O Ivantsov; Aglaya G Iyevleva; Evgeny N Imyanitov
Journal:  Invest New Drugs       Date:  2015-08-20       Impact factor: 3.850

Review 8.  Hairy cell leukemia-new genes, new targets.

Authors:  Robert J Kreitman
Journal:  Curr Hematol Malig Rep       Date:  2013-09       Impact factor: 3.952

Review 9.  ENDOCRINE TUMORS: BRAF V600E mutations in papillary craniopharyngioma.

Authors:  Priscilla K Brastianos; Sandro Santagata
Journal:  Eur J Endocrinol       Date:  2015-11-12       Impact factor: 6.664

10.  BRAF V600E-Negative Hairy Cell Leukaemia.

Authors:  Stephen E Langabeer; David O'Brien; Anthony M McElligott; Michelle Lavin; Paul V Browne
Journal:  Case Rep Hematol       Date:  2013-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.